The role of adipose tissue dysfunction in hepatic insulin resistance and T2D
Journal of Endocrinology · 05.07.2024 · 262 (3)
DOI: 10.1530/joe-24-0115 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Endocrinology, erschienen am 05.07.2024. Verfasst von Gencer Sancar und 1 weiteren Autor:innen. Beteiligte Einrichtung: German Center for Diabetes Research, Neuherberg, Germany. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes Mellitus, Type 2, Adipose Tissue, Liver. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The root cause of type 2 diabetes (T2D) is insulin resistance (IR), defined by the failure of cells to respond to circulating insulin to maintain lipid and glucose homeostasis. While the causes of whole-body insulin resistance are multifactorial, a major contributing factor is dysregulation of liver and adipose tissue function. Adipose dysfunction, particularly adipose tissue-IR (adipo-IR), plays a crucial role in the development of hepatic insulin resistance and the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) in the context of T2D. In this review, we will focus on molecular mechanisms of hepatic insulin resistance and its association with adipose tissue function. A deeper understanding of the pathophysiological mechanisms of the transition from a healthy state to insulin resistance, impaired glucose tolerance, and T2D may enable us to prevent and intervene in the progression to T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- German Center for Diabetes Research, Neuherberg, Germany.
- Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, Eberhard-Karls University of Tübingen, Tübingen, Germany.
- Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, Eberhard-Karls University of Tübingen, Tübingen, Germany.
ORCID-Profile: Andreas L Birkenfeld
Zitieren
APA
Sancar, G., & Birkenfeld, A. L. (2024). The role of adipose tissue dysfunction in hepatic insulin resistance and T2D. Journal of Endocrinology, 262(3). https://doi.org/10.1530/joe-24-0115
Vancouver
Sancar G, Birkenfeld AL. The role of adipose tissue dysfunction in hepatic insulin resistance and T2D. Journal of Endocrinology. 2024;262(3). doi:10.1530/joe-24-0115
BibTeX
@article{Sancar2024,
author = {Sancar, Gencer and Birkenfeld, Andreas L},
title = {The role of adipose tissue dysfunction in hepatic insulin resistance and T2D},
journal = {Journal of Endocrinology},
year = {2024},
volume = {262},
number = {3},
doi = {10.1530/joe-24-0115}
}
EUVIMED